BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 10680925)

  • 1. Consequences to hearing during the conservative management of vestibular schwannomas.
    Walsh RM; Bath AP; Bance ML; Keller A; Rutka JA
    Laryngoscope; 2000 Feb; 110(2 Pt 1):250-5. PubMed ID: 10680925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conservative management of vestibular schwannomas - second review of a prospective longitudinal study.
    Raut VV; Walsh RM; Bath AP; Bance ML; Guha A; Tator CH; Rutka JA
    Clin Otolaryngol Allied Sci; 2004 Oct; 29(5):505-14. PubMed ID: 15373864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The natural history of untreated vestibular schwannomas. Is there a role for conservative management?
    Walsh RM; Bath AP; Bance ML; Keller A; Tator CH; Rutka JA
    Rev Laryngol Otol Rhinol (Bord); 2000; 121(1):21-6. PubMed ID: 10865479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk of hearing loss in nongrowing, conservatively managed acoustic neuromas.
    Warrick P; Bance M; Rutka J
    Am J Otol; 1999 Nov; 20(6):758-62. PubMed ID: 10565721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hearing in patients with intracanalicular vestibular schwannomas.
    Caye-Thomasen P; Dethloff T; Hansen S; Stangerup SE; Thomsen J
    Audiol Neurootol; 2007; 12(1):1-12. PubMed ID: 17033159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conservative treatment of vestibular schwannoma: a follow-up study on clinical and quality-of-life outcome.
    Godefroy WP; Kaptein AA; Vogel JJ; van der Mey AG
    Otol Neurotol; 2009 Oct; 30(7):968-74. PubMed ID: 19730147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gamma knife radiosurgery for vestibular schwannomas: results of hearing preservation in relation to the cochlear radiation dose.
    Timmer FC; Hanssens PE; van Haren AE; Mulder JJ; Cremers CW; Beynon AJ; van Overbeeke JJ; Graamans K
    Laryngoscope; 2009 Jun; 119(6):1076-81. PubMed ID: 19399836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conservative management versus surgery for small vestibular schwannomas.
    Bozorg Grayeli A; Kalamarides M; Ferrary E; Bouccara D; El Gharem H; Rey A; Sterkers O
    Acta Otolaryngol; 2005 Oct; 125(10):1063-8. PubMed ID: 16298787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamma knife radiosurgery for vestibular schwannoma: early hearing outcomes and evaluation of the cochlear dose.
    Lasak JM; Klish D; Kryzer TC; Hearn C; Gorecki JP; Rine GP
    Otol Neurotol; 2008 Dec; 29(8):1179-86. PubMed ID: 18931646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in the management of vestibular schwannomas at Johns Hopkins 1997-2007.
    Tan M; Myrie OA; Lin FR; Niparko JK; Minor LB; Tamargo RJ; Francis HW
    Laryngoscope; 2010 Jan; 120(1):144-9. PubMed ID: 19877188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hearing preservation after intracanalicular vestibular schwannoma radiosurgery.
    Niranjan A; Mathieu D; Flickinger JC; Kondziolka D; Lunsford LD
    Neurosurgery; 2008 Dec; 63(6):1054-62; discussion 1062-3. PubMed ID: 19057318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conservative management of vestibular schwannomas: third review of a 10-year prospective study.
    Hajioff D; Raut VV; Walsh RM; Bath AP; Bance ML; Guha A; Tator CH; Rutka JA
    Clin Otolaryngol; 2008 Jun; 33(3):255-9. PubMed ID: 18559034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linear accelerator-based stereotactic radiosurgery for bilateral vestibular schwannomas in patients with neurofibromatosis type 2.
    Meijer OW; Vandertop WP; Lagerwaard FJ; Slotman BJ
    Neurosurgery; 2008 May; 62(5 Suppl):A37-42; discussion A42-3. PubMed ID: 18580779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conservative management of bilateral vestibular schwannomas in neurofibromatosis type 2 patients: hearing and tumor growth results.
    Peyre M; Goutagny S; Bah A; Bernardeschi D; Larroque B; Sterkers O; Kalamarides M
    Neurosurgery; 2013 Jun; 72(6):907-13; discussion 914; quiz 914. PubMed ID: 23407292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cochlear microphonics for hearing preservation in vestibular schwannoma surgery.
    Noguchi Y; Komatsuzaki A; Nishida H
    Laryngoscope; 1999 Dec; 109(12):1982-7. PubMed ID: 10591359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are stage IV vestibular schwannomas preoperatively different from other stages?
    Tringali S; Dubreuil C; Zaouche S; Ferber-Viart C
    Otol Neurotol; 2008 Jan; 29(1):46-9. PubMed ID: 18046259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concordance of bilateral vestibular schwannoma growth and hearing changes in neurofibromatosis 2: neurofibromatosis 2 natural history consortium.
    Fisher LM; Doherty JK; Lev MH; Slattery WH
    Otol Neurotol; 2009 Sep; 30(6):835-41. PubMed ID: 19704365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor growth and audiometric change in vestibular schwannomas managed conservatively.
    Massick DD; Welling DB; Dodson EE; Scholfield M; Nagaraja HN; Schmalbrock P; Chakeres DW
    Laryngoscope; 2000 Nov; 110(11):1843-9. PubMed ID: 11081597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conservative management of vestibular schwannomas: an effective strategy.
    Ferri GG; Modugno GC; Pirodda A; Fioravanti A; Calbucci F; Ceroni AR
    Laryngoscope; 2008 Jun; 118(6):951-7. PubMed ID: 18438269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of vestibular schwannoma growth and clinical implications.
    Agrawal Y; Clark JH; Limb CJ; Niparko JK; Francis HW
    Otol Neurotol; 2010 Jul; 31(5):807-12. PubMed ID: 20502379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.